Concepedia

Author

Ayako Shiraishi

Nagasaki University

Also Known As

A Shira-ishi, A Shiraishi, A. SHIRAISHI, A. Shiraishi, Ayako SHIRAISHI, Ayako Shira-Ishi, Ayako Shiraishi, Ayane Shiraishi

46

Publications

1.2K

Citations

18

H-Index

29

Concepts

All Affiliations

Nagasaki UniversityUniversity of Occupational and Environmental Health JapanJapanese Foundation For Cancer ResearchNational Center for Geriatrics and GerontologyChugai Pharma (United States)
AS

About

Ayako Shiraishi is an author at Nagasaki University specializing in osteoporosis, bone metabolism, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

16

804

2

Health Sciences

6

6

435

3

Engineering

5

5

300

4

Applied Physiology

1

1

137

5

Biomedical Engineering

1

1

50

Ayako Shiraishi

×

22

Publications

1.2K

Citations

18

H-Index

YearCitations

Alfacalcidol Inhibits Bone Resorption and Stimulates Formation in an Ovariectomized Rat Model of Osteoporosis: Distinct Actions from Estrogen

Ayako Shiraishi, Satoshi Takeda, Toshimi Masaki,

Journal of Bone and Mineral Research

2000

152

Contribution of trabecular and cortical components to the mechanical properties of bone and their regulating parameters

M. Ito, Akifumi Nishida, Aoi Koga,

Bone

2002

137

ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis

Yasushi Uchiyama, Y. Higuchi, Satoshi Takeda,

Bone

2002

120

The Advantage of Alfacalcidol Over Vitamin D in the Treatment of Osteoporosis

Ayako Shiraishi, Sayumi Higashi, Hiroyuki Ohkawa,

Calcified Tissue International

1999

84

Vitamin D Hormone Inhibits Osteoclastogenesis In Vivo by Decreasing the Pool of Osteoclast Precursors in Bone Marrow

Takeshi Shibata, Ayako Shiraishi, Takuya Sato,

Journal of Bone and Mineral Research

2002

77

A Comparison of Alfacalcidol and Menatetrenone for the Treatment of Bone Loss in an Ovariectomized Rat Model of Osteoporosis

Ayako Shiraishi, Sayumi Higashi, Tsuneo Masaki,

Calcified Tissue International

2002

73

Transgenic Mice Overexpressing Macrophage Migration Inhibitory Factor (MIF) Exhibit High-Turnover Osteoporosis

Shin Onodera, Satoshi Sasaki, Shigeki Ohshima,

Journal of Bone and Mineral Research

2006

61

1-Alpha, 25-dihydroxy vitamin D3 inhibits osteoclastogenesis through IFN-beta-dependent NFATc1 suppression

Sadaoki Sakai, Hironari Takaishi, Kenichiro MATSUZAKI,

Journal of Bone and Mineral Metabolism

2009

60

Efficacy and safety of fixed doses of intranasal Esketamine as an add-on therapy to Oral antidepressants in Japanese patients with treatment-resistant depression: a phase 2b randomized clinical study

Nagahide Takahashi, Aya Yamada, Ayako Shiraishi,

BMC Psychiatry

2021

54

Reductions in bone turnover, mineral, and structure associated with mechanical properties of lumbar vertebra and femur in glucocorticoid-treated growing minipigs

Satoshi Ikeda, Yoshiomi Morishita, Hideki Tsutsumi,

Bone

2003

53

Page 1